The problem with JAMA’s new vitamin K study

A new study published in JAMA has reignited debate over routine newborn vitamin K injections.

Analysing records of more than five million infants, the researchers reported a 47% higher risk of bleeding during the first six months of life among those without an injection.

The findings quickly attracted attention. JAMA promoted the study, while an accompanying editorial called for stronger public education and policy action.

On social media, reactions were polarised.

Some critics pointed to the product’s boxed warning about fatal hypersensitivity, while others like journalist Alex Berenson declared the routine injection “a no-brainer” and the decision to forgo it “dumb.”

But when I examined the study’s original protocol and supplementary data, I found problems that raised serious doubts about the reliability of the published risk estimates — and troubling questions about how the study passed peer review.

I have previously examined the benefits, risks and reasons why some parents decline vitamin K for newborns, so I won’t revisit those arguments here.

My concern is the quality of the research now being used to influence medical decisions, particularly when independent researchers cannot readily access the underlying data to verify the findings.


Read more

 

IPAK-EDU is grateful to MD REPORTS as this piece was originally published there and is included in this news feed with mutual agreement. Read More

Subscribe to SciPublHealth


Science-based knowledge, not narrative-dictated knowledge, is the goal of WSES, and we will work to make sure that only objective knowledge is used in the formation of medical standards of care and public health policies.

Comments


Join the conversation! We welcome your thoughts, feedback, and questions. Share your comments below.

Leave a Reply

De-Corrupting Medicine - a LIVE IPAK-EDU course with James Lyons-Weiler, PhD
  • Feds for Freedom